BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22479563)

  • 1. C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity.
    Denis C; Deiteren K; Mortier A; Tounsi A; Fransen E; Proost P; Renauld JC; Lambeir AM
    PLoS One; 2012; 7(3):e34199. PubMed ID: 22479563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I.
    Louahed J; Struyf S; Demoulin JB; Parmentier M; Van Snick J; Van Damme J; Renauld JC
    Eur J Immunol; 2003 Feb; 33(2):494-501. PubMed ID: 12645948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
    Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
    J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway.
    Spinetti G; Bernardini G; Camarda G; Mangoni A; Santoni A; Capogrossi MC; Napolitano M
    J Leukoc Biol; 2003 Jan; 73(1):201-7. PubMed ID: 12525579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.
    Zychowska M; Rojewska E; Piotrowska A; Kreiner G; Nalepa I; Mika J
    Int Immunopharmacol; 2017 Nov; 52():261-271. PubMed ID: 28961489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptor CCR8 is required for lipopolysaccharide-triggered cytokine production in mouse peritoneal macrophages.
    Oshio T; Kawashima R; Kawamura YI; Hagiwara T; Mizutani N; Okada T; Otsubo T; Inagaki-Ohara K; Matsukawa A; Haga T; Kakuta S; Iwakura Y; Hosokawa S; Dohi T
    PLoS One; 2014; 9(4):e94445. PubMed ID: 24714157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists.
    Liu L; Doijen J; D'huys T; Verhaegen Y; Dehaen W; De Jonghe S; Schols D; Van Loy T
    Biochem Pharmacol; 2021 Jun; 188():114565. PubMed ID: 33872569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.
    Haque NS; Fallon JT; Pan JJ; Taubman MB; Harpel PC
    Blood; 2004 Feb; 103(4):1296-304. PubMed ID: 14576057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.
    Das S; Sarrou E; Podgrabinska S; Cassella M; Mungamuri SK; Feirt N; Gordon R; Nagi CS; Wang Y; Entenberg D; Condeelis J; Skobe M
    J Exp Med; 2013 Jul; 210(8):1509-28. PubMed ID: 23878309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice.
    Vila-Caballer M; González-Granado JM; Zorita V; Abu Nabah YN; Silvestre-Roig C; Del Monte-Monge A; Molina-Sánchez P; Ait-Oufella H; Andrés-Manzano MJ; Sanz MJ; Weber C; Kremer L; Gutiérrez J; Mallat Z; Andrés V
    J Mol Cell Cardiol; 2019 Jul; 132():154-163. PubMed ID: 31121182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.
    Barington L; Rummel PC; Lückmann M; Pihl H; Larsen O; Daugvilaite V; Johnsen AH; Frimurer TM; Karlshøj S; Rosenkilde MM
    J Biol Chem; 2016 Jul; 291(31):16208-20. PubMed ID: 27226537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2-mediated inflammation.
    Knipfer L; Schulz-Kuhnt A; Kindermann M; Greif V; Symowski C; Voehringer D; Neurath MF; Atreya I; Wirtz S
    J Exp Med; 2019 Dec; 216(12):2763-2777. PubMed ID: 31537642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR8 Signaling
    Kang L; Schmalzl A; Leupold T; Gonzalez-Acera M; Atreya R; Neurath MF; Becker C; Wirtz S
    Front Immunol; 2020; 11():609400. PubMed ID: 33613532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
    Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
    Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
    J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions.
    Hoshino A; Kawamura YI; Yasuhara M; Toyama-Sorimachi N; Yamamoto K; Matsukawa A; Lira SA; Dohi T
    J Immunol; 2007 Apr; 178(8):5296-304. PubMed ID: 17404314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis.
    Gonzalo JA; Qiu Y; Lora JM; Al-Garawi A; Villeval JL; Boyce JA; Martinez-A C; Marquez G; Goya I; Hamid Q; Fraser CC; Picarella D; Cote-Sierra J; Hodge MR; Gutierrez-Ramos JC; Kolbeck R; Coyle AJ
    J Immunol; 2007 Aug; 179(3):1740-50. PubMed ID: 17641040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR8
    Barsheshet Y; Wildbaum G; Levy E; Vitenshtein A; Akinseye C; Griggs J; Lira SA; Karin N
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6086-6091. PubMed ID: 28533380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR8 signaling influences Toll-like receptor 4 responses in human macrophages in inflammatory diseases.
    Reimer MK; Brange C; Rosendahl A
    Clin Vaccine Immunol; 2011 Dec; 18(12):2050-9. PubMed ID: 21976223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal CCL1/CCR8 regulates phosphorylation of GluA1-containing AMPA receptor in postoperative pain after tibial fracture and orthopedic surgery in mice.
    Wang C; Xu R; Wang X; Li Q; Li Y; Jiao Y; Zhao Q; Guo S; Su L; Yu Y; Yu Y
    Neurosci Res; 2020 May; 154():20-26. PubMed ID: 31121204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.